Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Glaukos Corp (GKOS)
Glaukos Corp (GKOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,123,688
  • Shares Outstanding, K 48,800
  • Annual Sales, $ 282,860 K
  • Annual Income, $ -99,200 K
  • 60-Month Beta 1.11
  • Price/Sales 11.24
  • Price/Cash Flow N/A
  • Price/Book 6.65
Trade GKOS with:

Options Overview Details

View History
  • Implied Volatility 58.26% ( +2.39%)
  • Historical Volatility 44.86%
  • IV Percentile 97%
  • IV Rank 74.19%
  • IV High 69.19% on 02/22/23
  • IV Low 26.83% on 05/22/23
  • Put/Call Vol Ratio 2.70
  • Today's Volume 174
  • Volume Avg (30-Day) 554
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 12,409
  • Open Int (30-Day) 9,976

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.56
  • Number of Estimates 8
  • High Estimate -0.52
  • Low Estimate -0.60
  • Prior Year -0.53
  • Growth Rate Est. (year over year) -5.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.22 +9.64%
on 11/27/23
67.94 -4.43%
on 11/15/23
+0.72 (+1.12%)
since 11/03/23
3-Month
59.22 +9.64%
on 11/27/23
79.69 -18.52%
on 09/28/23
-8.65 (-11.76%)
since 09/05/23
52-Week
40.45 +60.52%
on 12/28/22
80.28 -19.12%
on 07/19/23
+19.05 (+41.52%)
since 12/05/22

Most Recent Stories

More News
Glaukos: Q3 Earnings Snapshot

Glaukos: Q3 Earnings Snapshot

GKOS : 65.05 (+1.62%)
Glaukos: Q2 Earnings Snapshot

Glaukos: Q2 Earnings Snapshot

GKOS : 65.05 (+1.62%)
These 2 Soaring Stocks Finished the Week Strong

Wall Street coasted into the close on Friday but still had a good week.

COMP : 2.52 (-0.40%)
$NASX : 14,210.30 (+0.17%)
$SPX : 4,566.68 (-0.07%)
$DOWI : 36,112.46 (-0.25%)
AEHR : 24.73 (+0.16%)
GKOS : 65.05 (+1.62%)
WFC : 44.56 (-1.24%)
Stock Index Futures Muted as Weak China Trade Data Weighs on Sentiment

June S&P 500 futures (ESM23) are up +0.14%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.09% this morning as weak trade data from China stoked investor concerns over the strength of global demand....

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
PACW : 7.54 (-2.71%)
WAL : 53.72 (-2.59%)
INTC : 41.95 (-0.94%)
AMD : 118.02 (-0.46%)
COIN : 142.84 (+1.24%)
ITX.E.DX : 38.620 (+0.52%)
YEXT : 6.96 (-1.14%)
GDYN : 12.16 (-3.11%)
VXRT : 0.7071 (-3.40%)
DAWN : 12.01 (-1.23%)
Glaukos Announces FDA Acceptance of NDA Submission for iDose TR

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 65.05 (+1.62%)
Glaukos' (GKOS) Q1 Earnings Beat Estimates, Sales Rise Y/Y

Glaukos' (GKOS) Q1 revenues beat estimates but fall year over year. Sales and gross margin improve, while higher operating expenses lead to wider operating loss.

ISRG : 308.55 (-1.06%)
EW : 68.24 (-1.36%)
HOLX : 69.06 (-2.15%)
GKOS : 65.05 (+1.62%)
Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates

Glaukos (GKOS) delivered earnings and revenue surprises of 3.28% and 10.38%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

GKOS : 65.05 (+1.62%)
GMED : 45.45 (-1.86%)
Glaukos: Q1 Earnings Snapshot

Glaukos: Q1 Earnings Snapshot

GKOS : 65.05 (+1.62%)
Glaukos Announces First Quarter 2023 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 65.05 (+1.62%)
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced...

GKOS : 65.05 (+1.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an...

See More

Key Turning Points

3rd Resistance Point 67.70
2nd Resistance Point 66.58
1st Resistance Point 65.30
Last Price 65.05
1st Support Level 62.90
2nd Support Level 61.78
3rd Support Level 60.50

See More

52-Week High 80.28
Fibonacci 61.8% 65.06
Last Price 65.05
Fibonacci 50% 60.36
Fibonacci 38.2% 55.67
52-Week Low 40.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar